Abstract
A simple and sensitive GC-EI-MS method using solvent extraction and evaporation was developed for the determination of olanzapine concentrations in plasma samples. Because olanzapine and promazine, which was used as the internal standard (IS), are nitrogenous bases, they can adsorb to the weakly acidic silanol groups on the surfaces of glass centrifuge tubes during solvent extraction and evaporation. Silylation of the glass tubes, addition of triethylamine (TEA), and use of a sample solution with a basic pH could prevent adsorption loss. The extraction method involved mixing plasma (500 μL) in a silylated glass tube with a promazine solution (2 μg/mL, 25 μL) in methanol containing 1% TEA. After addition of aqueous sodium carbonate (0.5 mol/L, pH 11.1, 1 mL) and extraction into 3 mL of dichloromethane/n-hexane (1:1, v/v) containing 1% TEA, the organic phase was evaporated to dryness in a silylated glass tube. The residue was dissolved in ethyl acetate containing 1% TEA (50 μL). For GC-EI-MS analysis, the calibration curves of olanzapine in human plasma were linear from 0.5 to 100 ng/mL. Intra- and interday precisions in plasma were both less than 7.36% (coefficient of variation), and the accuracy was between 94.6 and 110% for so...Continue Reading
References
May 1, 1976·Clinical Pharmacology and Therapeutics·S N HuntA M Yurchak
Jan 1, 1991·Clinical Pharmacology and Therapeutics·W Kalow, B K Tang
Oct 1, 1988·British Journal of Clinical Pharmacology·D SesardicD S Davies
Apr 1, 1987·Annals of Internal Medicine·B L LeeP Jacob
Jan 1, 1984·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A R Boobis, D S Davies
Jun 9, 1995·Journal of Chromatography. B, Biomedical Applications·J T CatlowS P Swanson
Apr 1, 1993·The American Journal of Psychiatry·A H Glassman
Jun 1, 1997·Therapeutic Drug Monitoring·M AravagiriS R Marder
Dec 10, 1998·Journal of Analytical Toxicology·A J JenkinsH N Raaf
Oct 8, 1999·Clinical Pharmacokinetics·J T CallaghanC M Beasley
Nov 22, 2000·JAMA : the Journal of the American Medical Association·K LasserD H Bor
Feb 24, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·M A RaggiV Volterra
Sep 21, 2001·The American Journal of Forensic Medicine and Pathology·T C MerrickA J Jenkins
Jul 27, 2002·Therapeutic Drug Monitoring·Elisabeth SkoghFinn Bengtsson
Mar 20, 2003·Journal of Mass Spectrometry : JMS·Carsten KratzschHans H Maurer
Oct 15, 2003·The American Journal of the Medical Sciences·Douglas ZiedonisDavid Smelson
Mar 17, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Zhiling ZhouHuande Li
Aug 4, 2004·Clinical Pharmacology and Therapeutics·Mirko S Faber, Uwe Fuhr
Sep 1, 2004·Journal of Pharmaceutical and Biomedical Analysis·C ChinH T Karnes
Jun 4, 2005·Journal of Forensic Sciences·Erica L Horak, Amanda J Jenkins
Mar 1, 2006·Journal of Pharmaceutical and Biomedical Analysis·Ramakrishna V S NirogiAnjaneyulu Yerramilli
Jul 26, 2008·Biomedical Chromatography : BMC·W R Wan AasimS C Tan
May 28, 2009·Journal of Analytical Toxicology·Marie Katrine Klose Nielsen, Sys Stybe Johansen
May 11, 2010·Journal of Pharmaceutical and Biomedical Analysis·Martin JosefssonMarja-Liisa Dahl
Jul 22, 2010·Journal of Mass Spectrometry : JMS·Eva SaarJochen Beyer